Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 4
2006 1
2008 2
2009 2
2011 1
2012 3
2013 4
2014 10
2015 5
2016 4
2017 5
2018 1
2019 5
2020 5
2021 13
2022 14
2023 8
2024 10
2025 14
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Management of Migraine.
Albanese M. Albanese M. J Clin Med. 2022 Sep 4;11(17):5225. doi: 10.3390/jcm11175225. J Clin Med. 2022. PMID: 36079154 Free PMC article.
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study).
Iannone LF, Vaghi G, Sebastianelli G, Casillo F, Russo A, Silvestro M, Pistoia F, Volta GD, Cortinovis M, Chiarugi A, Montisano DA, Prudenzano MP, Cevoli S, Mampreso E, Avino G, Romozzi M, Valente M, Fasano C, Battistini S, Granato A, Piella EM, Rainero I, Ornello R, De Icco R; Italian Headache Registry (RICe) Study Group. Iannone LF, et al. J Headache Pain. 2025 Jan 6;26(1):4. doi: 10.1186/s10194-024-01935-8. J Headache Pain. 2025. PMID: 39762740 Free PMC article.
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
Caronna E, Gallardo VJ, Egeo G, Vázquez MM, Castellanos CN, Membrilla JA, Vaghi G, Rodríguez-Montolio J, Fabregat Fabra N, Sánchez-Caballero F, Jaimes Sánchez A, Muñoz-Vendrell A, Oliveira R, Gárate G, González-Osorio Y, Guisado-Alonso D, Ornello R, Thunstedt C, Fernández-Lázaro I, Torres-Ferrús M, Alpuente A, Torelli P, Aurilia C, Pére RL, Castrillo MJR, Icco R, Sances G, Broadhurst S, Ong HC, García AG, Campoy S, Sanahuja J, Cabral G, Beltrán Blasco I, Waliszewska-Prosół M, Pereira L, Layos-Romero A, Luzeiro I, Dorado L, Álvarez Escudero MR, May A, López-Bravo A, Martins IP, Sundal C, Irimia P, Lozano Ros A, Gago-Veiga AB, Juanes FV, Ruscheweyh R, Sacco S, Cuadrado-Godia E, García-Azorín D, Pascual J, Gil-Gouveia R, Huerta-Villanueva M, Rodriguez-Vico J, Viguera Romero J, Obach V, Santos-Lasaosa S, Ghadiri-Sani M, Tassorelli C, Díaz-de-Terán J, Díaz Insa S, Oria CG, Barbanti P, Pozo-Rosich P; EUREkA study group. Caronna E, et al. J Neurol Neurosurg Psychiatry. 2024 Sep 17;95(10):927-937. doi: 10.1136/jnnp-2023-333295. J Neurol Neurosurg Psychiatry. 2024. PMID: 38777579
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II).
Barbanti P, Aurilia C, Egeo G, Doretti A, d'Onofrio F, Scatena P, Rinalduzzi S, Vinciguerra L, Sansone M, Vecchio R, Drago V, Viticchi G, Bartolini M, Ranieri A, Bandettini di Poggio M, Baldisseri F, Mascarella D, Brusaferri F, Caputi L, Messina S, Autunno M, Valenza A, Orlando B, Distefano M, Borrello L, Pistoia F, Camarda C, Saporito G, Querzola G, Torelli P, Salerno A, Gragnani F, Petolicchio B, Carnevale A, Messina R, Filippi M, Tavani S, Fiorentini G, Bonassi S, Cevoli S, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. J Neurol. 2025 May 7;272(6):382. doi: 10.1007/s00415-025-13095-z. J Neurol. 2025. PMID: 40332560 Free PMC article.
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures.
Barbanti P, Egeo G, Pistoia F, Aurilia C, Scatena P, Rinalduzzi S, Strumia S, Salerno A, Frediani F, Galli A, Autunno M, Di Clemente L, Zucco M, Albanese M, Bono F, Bruno P, Borrello L, Messina S, Doretti A, Ranieri A, Camarda C, Vecchio R, Drago V, Fiorentini G, Tomino C, Bonassi S, Torelli P, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. Among authors: albanese m. J Headache Pain. 2025 May 19;26(1):122. doi: 10.1186/s10194-025-02068-2. J Headache Pain. 2025. PMID: 40389834 Free PMC article.
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
Barbanti P, Fiorentini G, Camarda C, Autunno M, Pistoia F, Aurilia C, d'Onofrio F, Egeo G, Carnevale A, Caproni S, Doretti A, Cherchi A, De Simone R, Zucco M, Rinalduzzi S, Colombo B, Filippi M, Quintana S, Russo M, Coppola A, Grugno R, Bartolini M, Viticchi G, Rao R, Albanese M, Vernieri F, Grazzi L, Robotti M, Di Summa A, Aguggia M, Di Poggio MLB, Finocchi C, Terlizzi R, Sansone M, Gragnani F, Querzani P, Perini F, Solla P, Favoni V, Ferrau L, Saporito G, Iannaccone E, Colosimo C, Messina S, Di Clemente L, Cortese F, Scatena P, Cosenza D, Brunelli N, Querzola G, Gai A, Cazzulo S, Tazza F, Guarinoni M, Ercoli T, Tavani S, Orlando B, Bono F, Bruno PA, Proietti S, Bonassi S, Tomino C, Porreca A, Torelli P, Cevoli S; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. Among authors: albanese m. J Headache Pain. 2025 Oct 2;26(1):199. doi: 10.1186/s10194-025-02146-5. J Headache Pain. 2025. PMID: 41039230 Free PMC article.
107 results